SUMO modification modulates the activity of calpain-2

Biochemical and Biophysical Research Communications

Volumn 384, Issue 4, 2009, Pages 444-449

  Wang, Hsueh Chun ^a,b   Huang, Yen Sung ^a,b   Ho, Chun Chen ^b   Jeng, Jen Chong ^a,b   Shih, Hsiu Ming ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Calpain 2; Cell mobility; SUMO modification

Indexed keywords

ARGININE; CALPAIN 2; LYSINE; PROTEIN SENP1; SUMO PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DNA REPAIR; ENZYME INHIBITION; ENZYME MECHANISM; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRESS; SUMOYLATION; TRANSCRIPTION REGULATION; YEAST;

ANIMALS; CALPAIN; CELL MOVEMENT; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOPEPTIDASES; HUMANS; LYSINE; MUTATION; SUMO-1 PROTEIN;

EID: 65649142207     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.152     Document Type: Article

References (30)

1. Franco S.J., and Huttenlocher A. Regulating cell migration: calpains make the cut. J. Cell Sci. 118 (2005) 3829-3838
2. Wells A., Huttenlocher A., and Lauffenburger D.A. Calpain proteases in cell adhesion and motility. Int. Rev. Cytol. 245 (2005) 1-16
3. Croall D.E., and Ersfeld K. The calpains: modular designs and functional diversity. Genome Biol. 8 (2007) 218
4. 2+ ions. J. Biochem. 90 (1981) 275-278
5. Glading A., Bodnar R.J., Reynolds I.J., Shiraha H., Satish L., Potter D.A., Blair H.C., and Wells A. Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol. Cell. Biol. 24 (2004) 2499-2512
6. Shiraha H., Glading A., Chou J., Jia Z., and Wells A. Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol. Cell. Biol. 22 (2002) 2716-2727
7. Geiss-Friedlander R., and Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell. Biol. 8 (2007) 947-956
8. Kerscher O., Felberbaum R., and Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 22 (2006) 159-180
9. Rodriguez M.S., Dargemont C., and Hay R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276 (2001) 12654-12659
10. Hay R.T. SUMO: a history of modification. Mol. Cell 18 (2005) 1-12
11. Palvimo J.J. PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. Biochem. Soc. Trans. 35 (2007) 1405-1408
12. Wotton D., and Merrill J.C. Pc2 and SUMOylation. Biochem. Soc. Trans. 35 (2007) 1401-1404
13. Hay R.T. SUMO-specific proteases: a twist in the tail. Trends Cell Biol. 17 (2007) 370-376
14. Mukhopadhyay D., and Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32 (2007) 286-295
15. Yeh E.T. SUMOylation and De-SUMOylation: wrestling with life's processes. J. Biol. Chem. 284 (2009) 8223-8227
16. Kirkin V., and Dikic I. Role of ubiquitin- and Ubl-binding proteins in cell signaling. Curr. Opin. Cell Biol. 19 (2007) 199-205
17. Martin S., Wilkinson K.A., Nishimune A., and Henley J.M. Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat. Rev. Neurosci. 8 (2007) 948-959
18. Zhao J. Sumoylation regulates diverse biological processes. Cell. Mol. Life Sci. 64 (2007) 3017-3033
19. Li Z., Day C.P., Yang J.Y., Tsai W.B., Lozano G., Shih H.M., and Hung M.C. Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53. Cancer Res. 64 (2004) 9080-9085
20. Chang C.C., Lin D.Y., Fang H.I., Chen R.H., and Shih H.M. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4. J. Biol. Chem. 280 (2005) 10164-10173
21. Kuo H.Y., Chang C.C., Jeng J.C., Hu H.M., Lin D.Y., Maul G.G., Kwok R.P., and Shih H.M. SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx. Proc. Natl. Acad. Sci. USA 102 (2005) 16973-16978
22. Lin D.Y., Huang Y.S., Jeng J.C., Kuo H.Y., Chang C.C., Chao T.T., Ho C.C., Chen Y.C., Lin T.P., Fang H.I., Hung C.C., Suen C.S., Hwang M.J., Chang K.S., Maul G.G., and Shih H.M. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24 (2006) 341-354
23. Lin D.Y., Fang H.I., Ma A.H., Huang Y.S., Pu Y.S., Jenster G., Kung H.J., and Shih H.M. Negative modulation of androgen receptor transcriptional activity by Daxx. Mol. Cell. Biol. 24 (2004) 10529-10541
24. Knipscheer P., Flotho A., Klug H., Olsen J.V., van Dijk W.J., Fish A., Johnson E.S., Mann M., Sixma T.K., and Pichler A. Ubc9 sumoylation regulates SUMO target discrimination. Mol. Cell 31 (2008) 371-382
25. Knipscheer P., van Dijk W.J., Olsen J.V., Mann M., and Sixma T.K. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation. EMBO J. 26 (2007) 2797-2807
26. Dasso M. Emerging roles of the SUMO pathway in mitosis. Cell Div. 3 (2008) 5
27. Kadare G., Toutant M., Formstecher E., Corvol J.C., Carnaud M., Boutterin M.C., and Girault J.A. PIAS1-mediated sumoylation of focal adhesion kinase activates its autophosphorylation. J. Biol. Chem. 278 (2003) 47434-47440
28. 2+-regulated phospholipid-binding domain. Biochem. Biophys. Res. Commun. 280 (2001) 1333-1339
29. 2+ ions. J. Biol. Chem. 279 (2004) 20118-20126
30. Strobl S., Fernandez-Catalan C., Braun M., Huber R., Masumoto H., Nakagawa K., Irie A., Sorimachi H., Bourenkow G., Bartunik H., Suzuki K., and Bode W. The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc. Natl. Acad. Sci. USA 97 (2000) 588-592